Vir Biotechnology Inc
(MEX:VIR)
MXN
172
0 (0%)
Market Cap: 23.05 Bil
Enterprise Value: 4.84 Bil
PE Ratio: 0
PB Ratio: 0.84
GF Score: 54/100 Vir Biotechnology Inc (MEX:VIR) Transcripts
- Q1 2024 Vir Biotechnology Inc Earnings Call TranscriptMay 02, 2024MXN172Earnings
- Q4 2023 Vir Biotechnology Inc Earnings Call TranscriptFeb 22, 2024MXN172Earnings
- Vir Biotechnology Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Vir Biotechnology Inc AASLD Late Breaking Data Update Call TranscriptNov 13, 2023
- Q3 2023 Vir Biotechnology Inc Earnings Call TranscriptNov 02, 2023MXN172Earnings
- Vir Biotechnology Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Vir Biotechnology Inc Earnings Call TranscriptAug 03, 2023MXN420Earnings
- Vir Biotechnology Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Vir Biotechnology Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) TranscriptApr 18, 2023
- Vir Biotechnology Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Vir Biotechnology, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 09:45 AM TranscriptJan 10, 2023
- Vir Biotechnology Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 18, 2022
- Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Vir Biotechnology Inc Corporate Call on Sotrovimab's Retained Activity Against the Omicron SARS-CoV-2 Variant TranscriptDec 07, 2021
- Vir Biotechnology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- 1